Laboratory Research Pens: Recovery Stack 2026

Before purchasing the Recovery Stack pen set for laboratory research, verify:

• The exact SKU and compound list on the seller’s live product page, confirmed on the date of order
• A batch-level certificate of analysis (CoA) naming the lot number, test date, analytes, methods and the issuing laboratory
• Whether the testing laboratory holds UKAS (United Kingdom Accreditation Service) accreditation to ISO/IEC 17025 (the international standard for testing and calibration laboratories), and whether the scope covers the relevant analytes
• Cold-chain documentation separate from the CoA: logger files, stated temperature range and courier hand-off records
• The seller’s current GBP price, stock status and dispatch terms, no structured price or availability data is independently verified here

What this page covers: how to confirm bundle identity from batch documentation; what a CoA does and does not establish about a multi-pen stack; and which regulatory frameworks apply to research-use-only pen products in the United Kingdom.

Check current price and availability on the live product page before proceeding.

---

Offer Block

Field	Detail
Product	Recovery Stack Pen Set (BPC-157 + TB-500 40 · CJC-1295 + Ipamorelin 20)
Stated saving	12% versus individual pen prices
Price	Confirm live GBP price in the offer block before ordering
Availability	Confirm current stock status on the live product page
Purchase path	Veyvora Recovery Stack product page

---

Key Takeaways

• The Recovery Stack pairs two research pens: BPC-157 + TB-500 40 (tissue-repair research) and CJC-1295 + Ipamorelin 20 (growth-hormone secretagogue research), positioned as “tissue repair by day, growth-hormone support overnight.”
• The bundle carries a stated 12% saving; confirm bundle identity from the seller’s live product page and matching batch documentation on the date of order.
• A batch CoA is authoritative only for the specific analyte, batch number, test date and laboratory named on that document; it does not establish a combined effect across the full stack.
• Cold-chain integrity requires a separate temperature-logger record; a CoA alone does not confirm it.
• Both pens are supplied for in-vitro laboratory research only; classification as a medicine follows a product’s presentation and function, not its label, under the Human Medicines Regulations 2012 [4].

---

Specification Summary

Attribute	Detail
Format	Two pre-filled, multi-dose laboratory research pens
Components	BPC-157 + TB-500 40 · CJC-1295 + Ipamorelin 20
Stated saving	12% versus individual pen prices
Regulatory status (UK)	Research use only; subject to Human Medicines Regulations 2012 classification [4]
Batch evidence required	CoA with lot number, method, date and laboratory identity
Intended use	Research use only, not for human administration

The Human Medicines Regulations 2012 classify products by presentation and function, not by label [4]. Confirm the composition and batch documentation of the Recovery Stack pen set against the seller’s live page before supply.

Laboratory Research Pens: Recovery Stack 2026: Exact Bundle Identity

Veyvora’s Recovery Stack pairs a BPC-157 + TB-500 40 pen with a CJC-1295 + Ipamorelin 20 pen, positioned as “tissue repair by day, growth-hormone support overnight” and carrying a stated 12% bundle saving. Confirm the exact fill volumes, per-pen strengths, pen count and SKU from the seller’s live product page and matching batch documentation on the date of order, because catalogue quantities and specifications can change between batches.

Verify the following directly against the seller’s current listing and batch records before treating any bundle detail as settled:

• SKU and product name, confirm the exact identifier shown on the live page matches the label on each pen
• Compound list, each analyte must appear by name on a batch-level certificate of analysis, not only on marketing copy
• Fill volume and concentration per pen, stated in the batch CoA or product specification, not inferred from format
• Pen count and needle specification, confirmed from the live listing; quantities may change between batches
• Lot number, must match across the physical pen, the CoA and any cold-chain record; verify your batch against the published certificate before first use

All per-pen values below should be confirmed against the live page and the batch CoA before treating them as settled.

Included Components

The Recovery Stack contains two research pens: BPC-157 + TB-500 40, a tissue-repair blend, and CJC-1295 + Ipamorelin 20, a dual growth-hormone secretagogue pen. BPC-157 is studied in cytoprotection and angiogenesis-related repair models; TB-500 is studied for associations with actin regulation and cell migration, a complementary pathway, which is why the two are combined in one pen. CJC-1295 is a GHRH analogue and Ipamorelin is a selective GH-releasing peptide, pairing two mechanisms on the growth-hormone axis. Component details below are drawn from Veyvora’s live product page and batch-level documentation; values not yet confirmed from those sources are marked for operator verification.

Component Table

Component	Stated Strength / Format	Pen Volume	Needle Spec	Verification Status
BPC-157 + TB-500 40	40 mg blend (confirm split on CoA)	3 mL, 300-click	31G 6 mm	Confirm from live CoA
CJC-1295 + Ipamorelin 20	20 mg secretagogue pairing (confirm split on CoA)	3 mL, 300-click	31G 6 mm	Confirm from live CoA
Pen needles (included)	31G 6 mm (Veyvora, 2026)	Pre-packed per pen	—	Supplier-stated
Dosing card	Printed, per pen (Veyvora, 2026)	—	—	Supplier-stated
Cold-chain packaging	Insulated bag with a gel ice pack (Veyvora, 2026)	—	—	Supplier-stated

Veyvora states that each pre-filled multi-dose research pen is a 3 mL, 300-click format delivering 133 µg per click (Veyvora, 2026); this figure is a supplier statement, and each analyte must appear by name on the batch certificate of analysis before that component is treated as confirmed, because marketing copy alone does not constitute identity evidence.

For cold-chain requirements that apply once the pen set arrives, see storage and stability guidance. Buyers evaluating whether the complete stack matches their protocol can compare individual products in the Repair & Recovery Research Pens catalogue.

Bundle-level Evidence Boundary

Evidence for each component in the Recovery Stack does not establish a combined effect for the stack as a whole. A batch CoA is authoritative only for the specific analyte, batch number, test date and laboratory named on that document; it says nothing about how two or more compounds interact when used together in a research protocol.

What a CoA Does and Does Not Confirm

A CoA issued by a named laboratory, whether UKAS-accredited to ISO/IEC 17025 or otherwise, attaches to a single batch and a defined scope of testing. It confirms identity, purity and the stated assay method for that sample on that date. It does not:

• Confirm the identity or purity of every other pen in a multi-pen set dispatched under a different batch number
• Establish cold-chain integrity between dispatch and receipt (that requires a separate temperature-logger record)
• Constitute evidence of a combined physiological or biochemical effect across the full stack
• Transfer to a different analyte listed elsewhere in the same commercial bundle

Veyvora states that each batch is independently assayed by Asterion and its internal laboratory using HPLC (high-performance liquid chromatography), mass spectrometry and endotoxin assay, and publishes a batch-level CoA with a stated HPLC purity of at least 98.0% (Veyvora, 2026). That statement becomes usable evidence only when the batch number printed on each pen matches the number on the published certificate; the how to verify your batch page sets out that matching process. For what an HPLC purity figure does and does not confirm analytically, see what HPLC purity does and does not prove.

Because BPC-157 and TB-500 map to complementary repair pathways, and CJC-1295 and Ipamorelin address two arms of secretagogue signalling, the pairing is a research-format grouping rather than a compound with its own combined-outcome data. Buyers comparing individual research materials can consult the BPC-157 versus TB-500 comparison for component-level analytical context.

Batch Documents and Cold-Chain Records

Usable batch evidence for any pen in the Recovery Stack set requires four elements on the same document: the batch or lot number matching the physical pen, the test date, the named analytes and methods used, and the legal name of the testing laboratory together with any UKAS accreditation number and ISO/IEC 17025 scope reference.

Veyvora states that each batch is independently assayed by Asterion and its internal laboratory using HPLC, mass spectrometry and endotoxin assay, and publishes a batch-level certificate of analysis with a stated HPLC purity of at least 98.0% (Veyvora, 2026). Confirming that the batch number printed on each pen matches the number on the published certificate converts that supplier statement into usable evidence.

Handling and Storage Requirements

Cold-chain records are a separate document class. A certificate of analysis does not establish temperature integrity between dispatch and receipt; that requires a courier hand-off record or temperature-logger file showing the pen remained within the stated 2–8 °C range throughout transit. Veyvora states that orders are dispatched cold in an insulated bag with a gel ice pack (Veyvora, 2026). Whether a logger file is available for a given shipment must be confirmed with the supplier before use. For post-receipt storage requirements, consult the storage and stability guidance.

Vendor handling instructions supplied with the pen are merchant documentation, not MHRA authorisation or a licensed protocol [4]. Treat them accordingly when designing any research procedure.

Commercial Terms

Veyvora lists the Recovery Stack as a bundle-and-save offer with a stated 12% saving against the combined individual-pen prices. The resulting GBP figure, minimum order quantity, VAT treatment, stock level and delivery service-level agreement are not verified here; merchant pricing is authoritative only for the named seller on the date shown on their live offer page, and no figure should be inferred or carried forward from an earlier publication date.

Confirm the following directly from the live offer block before purchase or distribution:

• Current GBP unit price and the 12% multi-unit discount, with the date the price was confirmed
• VAT treatment applicable to research-use-only pen products under your purchasing entity’s status
• Stock availability and expected dispatch window at the time of order
• Minimum order quantity and any Incoterm or carriage arrangement for distributor accounts
• Returns or replacement policy in the event of cold-chain failure on receipt

Where the complete recovery stack does not match your procurement scope, the Repair & Recovery Research Pens catalogue lists individual pen formats for comparison.

Research-use-only Limitations

In the United Kingdom, a product’s legal classification as a medicinal product is determined by its presentation and function, not by a label [4]. Under the Human Medicines Regulations 2012, a product qualifies as a medicinal product if it is presented as treating or preventing disease, or if it is administered to restore, correct or modify physiological functions by pharmacological, immunological or metabolic action [4]. A “research use only” or “not for human consumption” label does not, by itself, settle that classification; the presentation and intended use of the product are assessed together.

Both pens in the Recovery Stack are supplied strictly for in-vitro laboratory research and are not authorised medicines in the United Kingdom. Two regulatory frameworks are sometimes misapplied to research-use-only pen products and should not be used as legal cover:

• EMA RUO (Research Use Only) language under IVDR (In Vitro Diagnostic Regulation) (EU) 2017/746 applies to certain in-vitro diagnostic devices used solely for research; it does not apply to multi-dose injectable peptide pens.
• UKAS accreditation attaches to a named laboratory, scope and method; it does not licence a pen product for supply or human use.

Before procurement, confirm the intended use of any pen set falls within a lawful research context.

Confirm current price, stock status and dispatch terms on the live product page before placing an order.

Sources

[1] Medicines and Healthcare products Regulatory Agency - GOV.UK, products.mhra.gov.uk, https://products.mhra.gov.uk/ [2] European Medicines Agency (EMA), products.mhra.gov.uk, 2023, https://products.mhra.gov.uk/ [4] legislation.gov.uk, https://www.legislation.gov.uk/uksi/2012/1916/body/data.xht?view=snippet&wrap=true